NEW YORK (GenomeWeb News) — GE Healthcare will stop manufacturing its CodeLink printed microarrays by April 2007 and will stop accepting requests from existing customers in February, the company told GenomeWeb News this week.
 
GE has not indicated that it will sell its CodeLink assets but said it will help clients switch to rival platforms as CodeLink is phased out, leaving the future of the 7-year-old microarray technology in limbo.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.